Method of treatment of type 2 diabetes mellitus comorbid with chronic toxic hepatitis with dpp-4 ingibitors and alpha-lipoic acid
dc.contributor.author | Tymoshenko, Galyna | |
dc.date.accessioned | 2013-10-10T06:53:15Z | |
dc.date.available | 2013-10-10T06:53:15Z | |
dc.date.issued | 2013 | |
dc.description.abstract | Type 2 diabetes mellitus (DM-2) is one of the most topical health and social problems of modern mankind. Liver disease comorbid with DM-2 is quite a common clinical situation. Liver injury is considered as one of the major complications of diabetes, so the severity of diabetes depends on the functional state of the liver. Chronic toxic hepatitis (CTH) had become a significant problem over past decades due to the growing industrialization and increasing prevalence of this disease. However, many issues concerning CTH remain understudied, including its diagnostic, therapeutic and preventive aspects | uk_UA |
dc.identifier.citation | Tymoshenko G. Method of treatment of type 2 diabetes mellitus comorbid with chronic toxic hepatitis with dpp-4 ingibitors and alpha-lipoic acid / G. Tymoshenko // 6th International Scientific Interdisciplinary Conference (ISIC) for medical students and young doctors, Kharkiv, 16–17 May 2013 : Abstract book / KhNMU. – Kharkiv, 2013. – Р. 95. | uk_UA |
dc.identifier.uri | https://repo.knmu.edu.ua/handle/123456789/3847 | |
dc.language.iso | en | uk_UA |
dc.subject | chronic toxic hepatitis | uk_UA |
dc.subject | type 2 diabetes mellitus | uk_UA |
dc.title | Method of treatment of type 2 diabetes mellitus comorbid with chronic toxic hepatitis with dpp-4 ingibitors and alpha-lipoic acid | uk_UA |
dc.type | Thesis | uk_UA |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Method of treatment of type 2 diabetes mellitus comorbid with chronic toxic hepatitis with dpp-4 ingibitors and alpha-lipoic acid.pdf
- Size:
- 160.46 KB
- Format:
- Adobe Portable Document Format
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 6.52 KB
- Format:
- Item-specific license agreed upon to submission
- Description: